Frank Pacholec, Vice President R&D at STEPAN CO (SCL), sold 4,000 shares at $86.00 ($347K) on 2017-04-25, disclosed to the SEC on 2017-04-27.
Scheduled sale ($346k) by Vice President R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.00 | 1,000 | $84K | 24.2% |
| 2 | $86.00 | 1,500 | $129K | 37.2% |
| 3 | $89.00 | 1,500 | $134K | 38.5% |
| Total | $86.63 avg | 4,000 | $347K | 100% |
| Filing → |
| SCL | SELL | 2018-09-14 | $45K | — | Filing → |
| SCL | SELL | 2018-09-10 | $61K | — | Filing → |
| SCL | SELL | 2018-08-13 | $73K | — | Filing → |